Sanofi SA
(LTS:0A2V)
$
49
0 (0%)
Market Cap: 122.85 Bil
Enterprise Value: 141.18 Bil
PE Ratio: 28.19
PB Ratio: 1.63
GF Score: 87/100 Sanofi SA at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 09, 2021 / 06:10PM GMT
Release Date Price:
$52.8
(+1.70%)
Keyur Parekh
Goldman Sachs Group, Inc., Research Division - Equity Analyst
Good afternoon, and good evening, and thank you all for joining us. My name is Keyur Parekh, and I cover Sanofi for Goldman Sachs. It is my distinct honor and privilege to welcome John Reed for this fireside chat. John, thank you very much for joining us.
John C. Reed
Sanofi - Executive VP and Global Head of Research & Development
Great to be here, Keyur.
Keyur Parekh
Goldman Sachs Group, Inc., Research Division - Equity Analyst
As most of you know, John is Executive Vice President and Head of R&D for Sanofi. And I believe, John, this is your first kind of Goldman Sachs conference. And it's a shame that we're doing this virtually and not in person at [Terranea]. But hopefully, we will resolve that soon enough.
John C. Reed
Sanofi - Executive VP and Global Head of Research & Development
No, it's great to be here. Thanks for the opportunity. I look forward to having this chat with
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot